Kenji Miki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kenji Miki has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
Masao Yukioka
Affiliation Faculty of Health Science, Osaka Yukioka College of Health Science, Ibaraki, Japan
10 shared publicationsKazuhiro Hayashi
Clinical Research Group, Japanese Association for the Study of Musculoskeletal Pain, Nagoya, Japan
6 shared publications- Kazuhiro Hayashi
Graduate School of Medicine, Human Health Sciences, Kyoto University, Kyoto, Japan
5 shared publications Hiroshi Kajiyama
Multidisciplinary Pain Center, Aichi Medical University, Nagakute, Japan
3 shared publicationsKenrin Shi
Department of Physical Therapy and Rehabilitation Science, University of Iowa, Iowa City, IA, United States
3 shared publicationsMasahiko Shibata
Pain Medicine and Research Information Center, Nonprofit Organization, Nagakute, Japan
3 shared publications
Latest Publications
- Open Access
- 31 July 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0354827
Personality traits have an effect on pain-related psychological variables in patients with chronic low back pain
Introduction: An association between personality factors and pain experience has been investigated. However, the direct contributions of personality traits by the Maudsley Personality Inventory to clinical pain outcomes in patients with chronic pain remain unclear. The Maudsley Personality Inventory is a self-report questionnaire used to assess extroversion, neurotic tendencies, and lying or exhibitionistic tendencies. The present study aimed to investigate whether personality traits influenced with the pain-related psychological variables in patients with chronic secondary low back pain (CLBP). Methods: One hundred fifteen consecutive outpatients with CLBP were included. Personality traits were measured by using the Maudsley Personality Inventory to assess extroversion, neurotic tendencies, and lying or exhibitionistic tendencies. The association of Maudsley neurotic tendency score and pain-related variables was analyzed and then performed a path analysis. Eleven patients (9%) were the biased persons with frequent lying. Results: The pain-related variables showed no significant differences between the persons with frequent lying and those with normal. The Maudsley neurotic tendency score was significantly associated with Pain Catastrophizing Scale, Hospital Anxiety and Depression Scale, Pain Self-Efficacy Questionnaire, Athens Insomnia Scale, and EuroQol-5 Dimensions-3 level. The unstandardized coefficients for Maudsley neurotic tendency score were small, compared to pain-Numerical Rating Scale in each outcome. Conclusions: These results suggest the presence of neurotic tendency could have an impact on the health outcomes in patients with CLBP, but the impact was small.
- 31 July 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0354827
Open AccessPersonality traits have an effect on pain-related psychological variables in patients with chronic low back pain
Introduction: An association between personality factors and pain experience has been investigated. However, the direct contributions of personality traits by the Maudsley Personality Inventory to clinical pain outcomes in patients with chronic pain remain unclear. The Maudsley Personality Inventory is a self-report questionnaire used to assess extroversion, neurotic tendencies, and lying or exhibitionistic tendencies. The present study aimed to investigate whether personality traits influenced with the pain-related psychological variables in patients with chronic secondary low back pain (CLBP). Methods: One hundred fifteen consecutive outpatients with CLBP were included. Personality traits were measured by using the Maudsley Personality Inventory to assess extroversion, neurotic tendencies, and lying or exhibitionistic tendencies. The association of Maudsley neurotic tendency score and pain-related variables was analyzed and then performed a path analysis. Eleven patients (9%) were the biased persons with frequent lying. Results: The pain-related variables showed no significant differences between the persons with frequent lying and those with normal. The Maudsley neurotic tendency score was significantly associated with Pain Catastrophizing Scale, Hospital Anxiety and Depression Scale, Pain Self-Efficacy Questionnaire, Athens Insomnia Scale, and EuroQol-5 Dimensions-3 level. The unstandardized coefficients for Maudsley neurotic tendency score were small, compared to pain-Numerical Rating Scale in each outcome. Conclusions: These results suggest the presence of neurotic tendency could have an impact on the health outcomes in patients with CLBP, but the impact was small.
- Open Access
- 9 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Randomized open-label non-inferiority trial of paracetamol or celecoxib for patients with chronic low back pain
Pharmacological treatment is commonly used for patients with chronic low back pain (CLBP). However, very low-quality evidence exists for paracetamol as a treatment option for CLBP; therefore, recommendations are contradictory among the guidelines. This randomized controlled study aimed to compare the analgesic effects of paracetamol and celecoxib in a non-inferiority trial. This non-inferiority trial tested the hypothesis that paracetamol is as effective as celecoxib for the treatment of CLBP within a pre-specified non-inferiority margin. One hundred fifty-six patients with CLBP were considered eligible and randomly allocated to a group receiving paracetamol or celecoxib. The pain intensity was measured using a numerical rating scale as the primary outcome. Secondary outcomes were pain-related psychological variables, quality of life, and adverse events. One hundred thirty-nine patients completed the study (paracetamol, 70; celecoxib, 69). We observed that the mean differences in the NRS changes between the two medication groups from baseline to weeks two and four did not significantly exceed the non-inferiority margin. Paracetamol had a superior effect on pain-related psychological variables and quality of life compared to celecoxib. These results suggest that paracetamol provides analgesic effects comparable to celecoxib for CLBP, meeting the criteria for non-inferiority.
- 9 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessRandomized open-label non-inferiority trial of paracetamol or celecoxib for patients with chronic low back pain
Pharmacological treatment is commonly used for patients with chronic low back pain (CLBP). However, very low-quality evidence exists for paracetamol as a treatment option for CLBP; therefore, recommendations are contradictory among the guidelines. This randomized controlled study aimed to compare the analgesic effects of paracetamol and celecoxib in a non-inferiority trial. This non-inferiority trial tested the hypothesis that paracetamol is as effective as celecoxib for the treatment of CLBP within a pre-specified non-inferiority margin. One hundred fifty-six patients with CLBP were considered eligible and randomly allocated to a group receiving paracetamol or celecoxib. The pain intensity was measured using a numerical rating scale as the primary outcome. Secondary outcomes were pain-related psychological variables, quality of life, and adverse events. One hundred thirty-nine patients completed the study (paracetamol, 70; celecoxib, 69). We observed that the mean differences in the NRS changes between the two medication groups from baseline to weeks two and four did not significantly exceed the non-inferiority margin. Paracetamol had a superior effect on pain-related psychological variables and quality of life compared to celecoxib. These results suggest that paracetamol provides analgesic effects comparable to celecoxib for CLBP, meeting the criteria for non-inferiority.
- Open Access
- 13 March 2025
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 134 (6) , 1756-1764
Motor cortex repetitive transcranial magnetic stimulation in fibromyalgia: a multicentre randomised controlled trial
- 13 March 2025
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 134 (6) , 1756-1764
Open AccessMotor cortex repetitive transcranial magnetic stimulation in fibromyalgia: a multicentre randomised controlled trial
- Open Access
- 9 January 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-11
Utilization of telemedicine in conjunction with wearable devices for patients with chronic musculoskeletal pain: a randomized controlled clinical trial
The present randomized controlled trial aimed to investigate the effects of home-based telemedicine with wearable devices and usual care on pain-related outcomes in patients with chronic musculoskeletal pain, compared to usual care alone. The patients with chronic musculoskeletal pain were randomly allocated to the usual care group or the telemedicine group, which participated in telemedicine with wearable devices, the objective data from which were recorded, in conjunction with usual care for six months. The primary outcome measure was the Numeric Rating Scale (NRS) for pain. The secondary outcome measures were the Pain Catastrophizing Scale (PCS), Hospital Anxiety and Depression Scale (HADS), Pain Disability Assessment Scale (PDAS), and EuroQol-five dimensions-three level (EQ-5D-3L). Seventy-one participants were analyzed. At 1 and 3 months, there were no significant differences in the NRS scores between the groups; however, the telemedicine group had a significantly superior effect on all of the outcome measures at 6 months compared to the usual care group. The number of steps and distance were significantly increased at 6 months compared to baseline in the telemedicine group. Home-based telemedicine with wearable devices and usual care has a modest effect on pain-related outcomes compared to usual care in patients with chronic musculoskeletal pain. This study was registered (UMIN000052994 - 04/12/2023).
- 9 January 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-11
Open AccessUtilization of telemedicine in conjunction with wearable devices for patients with chronic musculoskeletal pain: a randomized controlled clinical trial
The present randomized controlled trial aimed to investigate the effects of home-based telemedicine with wearable devices and usual care on pain-related outcomes in patients with chronic musculoskeletal pain, compared to usual care alone. The patients with chronic musculoskeletal pain were randomly allocated to the usual care group or the telemedicine group, which participated in telemedicine with wearable devices, the objective data from which were recorded, in conjunction with usual care for six months. The primary outcome measure was the Numeric Rating Scale (NRS) for pain. The secondary outcome measures were the Pain Catastrophizing Scale (PCS), Hospital Anxiety and Depression Scale (HADS), Pain Disability Assessment Scale (PDAS), and EuroQol-five dimensions-three level (EQ-5D-3L). Seventy-one participants were analyzed. At 1 and 3 months, there were no significant differences in the NRS scores between the groups; however, the telemedicine group had a significantly superior effect on all of the outcome measures at 6 months compared to the usual care group. The number of steps and distance were significantly increased at 6 months compared to baseline in the telemedicine group. Home-based telemedicine with wearable devices and usual care has a modest effect on pain-related outcomes compared to usual care in patients with chronic musculoskeletal pain. This study was registered (UMIN000052994 - 04/12/2023).
- Open Access
- 28 June 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (6) , e0287676
Predictors of high-cost patients with acute whiplash-associated disorder in Japan
The proportion of neck injuries due to traffic accidents is increasing. Little is known about high-cost patients with acute whiplash-associated disorder (WAD). The present study aimed to investigate whether time to first visit for conventional medicine, multiple doctor visits, or alternative medicine could predict high-cost patients with acute WAD in Japan. Data from a compulsory, no-fault, government automobile liability insurance agency in Japan between 2014 and 2019 were used. The primary economic outcome was the total cost of healthcare per person. Treatment-related variables were assessed based on the time to first visit for conventional and alternative medicine, multiple doctor visits, and visits for alternative medicine. Patients were categorized according to total healthcare cost (low, medium, and high cost). The variables were subjected to univariate and multivariate analysis to compare high-cost and low-cost patients. A total of 104,911 participants with a median age of 42 years were analyzed. The median total healthcare cost per person was 67,366 yen. The cost for consecutive medicine, for consecutive and alternative medicine, and total healthcare costs were significantly associated with all clinical outcomes. Female sex, being a homemaker, a history of WAD claim, residential area, patient responsibility in a traffic accident, multiple doctor visits, and visits for alternative medicine were identified as independent predictive factors for a high cost in multivariate analysis. Multiple doctor visits and visits for alternative medicine showed large differences between groups (odds ratios 2673 and 694, respectively). Patients with multiple doctor visits and visits for alternative medicine showed a significantly high total healthcare cost per person (292,346 yen) compared to those without (53,587 yen). A high total healthcare cost is strongly associated with multiple doctor visits and visits for alternative medicine in patients with acute WAD in Japan.
- 28 June 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (6) , e0287676
Open AccessPredictors of high-cost patients with acute whiplash-associated disorder in Japan
The proportion of neck injuries due to traffic accidents is increasing. Little is known about high-cost patients with acute whiplash-associated disorder (WAD). The present study aimed to investigate whether time to first visit for conventional medicine, multiple doctor visits, or alternative medicine could predict high-cost patients with acute WAD in Japan. Data from a compulsory, no-fault, government automobile liability insurance agency in Japan between 2014 and 2019 were used. The primary economic outcome was the total cost of healthcare per person. Treatment-related variables were assessed based on the time to first visit for conventional and alternative medicine, multiple doctor visits, and visits for alternative medicine. Patients were categorized according to total healthcare cost (low, medium, and high cost). The variables were subjected to univariate and multivariate analysis to compare high-cost and low-cost patients. A total of 104,911 participants with a median age of 42 years were analyzed. The median total healthcare cost per person was 67,366 yen. The cost for consecutive medicine, for consecutive and alternative medicine, and total healthcare costs were significantly associated with all clinical outcomes. Female sex, being a homemaker, a history of WAD claim, residential area, patient responsibility in a traffic accident, multiple doctor visits, and visits for alternative medicine were identified as independent predictive factors for a high cost in multivariate analysis. Multiple doctor visits and visits for alternative medicine showed large differences between groups (odds ratios 2673 and 694, respectively). Patients with multiple doctor visits and visits for alternative medicine showed a significantly high total healthcare cost per person (292,346 yen) compared to those without (53,587 yen). A high total healthcare cost is strongly associated with multiple doctor visits and visits for alternative medicine in patients with acute WAD in Japan.
- Open Access
- 19 June 2023
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 10, 1189748
Discordance of global assessment between the patients and physicians predicts 9-year pain-related outcomes in rheumatoid arthritis patients
Introduction: Perspectives regarding the disease state often differ between patients with rheumatoid arthritis (RA) and physicians. The aim of the present longitudinal cohort study was to investigate the impact of the discordance in global assessments between patients and physicians on 9-year pain-related outcomes in patients with rheumatoid arthritis.Method: Sixty-eight consecutive outpatients with rheumatoid arthritis on their first visit to a tertiary center were included. Baseline measurements included demographic data, drugs used, disease activity, and a modified Health Assessment Questionnaire (mHAQ). Discordance in global assessment between patients and physicians at baseline was defined as 10 mm higher in the patient global assessment (PGA) than in the physician global assessment. A 9-year follow-up assessment included pain intensity, the European Quality of Life 5 Dimensions 3 Level (EQ-5D-3L) scale, Pain Catastrophizing Scale (PCS), Hospital Anxiety and Depression Scale (HADS), Pain Disability Assessment Scale (PDAS), and Pain Self-Efficacy Questionnaire (PSEQ).Results: The number of patients with discordance was 26 (38%) in 68 patients. Patients with a 10 mm higher PGA than the physician global assessment at baseline measurements had significantly worse pain intensity, PCS score, PSEQ score, and EQ-5D-3L score measurements at the 9-year follow-up than those with concordance. A higher mHAQ score and 10 mm higher PGA at baseline were significantly independently associated with the EQ-5D-3L scale score and pain intensity at the 9-year follow-up.Conclusion: This longitudinal cohort study suggested that discordance in global assessment between patients and physicians modestly predicted worse 9-year pain-related outcomes in patients with rheumatoid arthritis.
- 19 June 2023
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 10, 1189748
Open AccessDiscordance of global assessment between the patients and physicians predicts 9-year pain-related outcomes in rheumatoid arthritis patients
Introduction: Perspectives regarding the disease state often differ between patients with rheumatoid arthritis (RA) and physicians. The aim of the present longitudinal cohort study was to investigate the impact of the discordance in global assessments between patients and physicians on 9-year pain-related outcomes in patients with rheumatoid arthritis.Method: Sixty-eight consecutive outpatients with rheumatoid arthritis on their first visit to a tertiary center were included. Baseline measurements included demographic data, drugs used, disease activity, and a modified Health Assessment Questionnaire (mHAQ). Discordance in global assessment between patients and physicians at baseline was defined as 10 mm higher in the patient global assessment (PGA) than in the physician global assessment. A 9-year follow-up assessment included pain intensity, the European Quality of Life 5 Dimensions 3 Level (EQ-5D-3L) scale, Pain Catastrophizing Scale (PCS), Hospital Anxiety and Depression Scale (HADS), Pain Disability Assessment Scale (PDAS), and Pain Self-Efficacy Questionnaire (PSEQ).Results: The number of patients with discordance was 26 (38%) in 68 patients. Patients with a 10 mm higher PGA than the physician global assessment at baseline measurements had significantly worse pain intensity, PCS score, PSEQ score, and EQ-5D-3L score measurements at the 9-year follow-up than those with concordance. A higher mHAQ score and 10 mm higher PGA at baseline were significantly independently associated with the EQ-5D-3L scale score and pain intensity at the 9-year follow-up.Conclusion: This longitudinal cohort study suggested that discordance in global assessment between patients and physicians modestly predicted worse 9-year pain-related outcomes in patients with rheumatoid arthritis.
- Open Access
- 1 January 2023
- Published by Society of Physical Therapy Science in Rigakuryoho Kagaku
- Vol. 38 (5) , 338-344
Stroop test実施中の中高年線維筋痛症患者における前頭前野の活動について
[Purpose] We measured prefrontal cortex activity during the Stroop test in middle- and old-aged fibromyalgia patients and middle- and old-aged healthy subjects using functional near-infrared spectroscopy, and examined and compared the results. [Participants and Methods] The Stroop test was performed in two groups of 10 middle- and old-aged fibromyalgia patients (experimental group) and 29 middle- and old-aged healthy subjects (control group), and prefrontal cortex activity was measured by functional near-infrared spectroscopy. Oxy-Hb values and Δoxy-Hb values representing task-induced deactivation were compared in two groups and three prefrontal regions, i.e., the right and left dorsolateral prefrontal cortex and the frontal pole. [Results] During the Stroop test, oxy-Hb values in the right dorsolateral prefrontal cortex were significantly higher in the middle- and old-aged healthy subjects than in middle- and old-aged fibromyalgia patients. The Δoxy-Hb value in the frontal pole of the middle- and old-aged fibromyalgia patients tended to be higher than those in the left and right dorsolateral prefrontal cortex. [Conclusion] During the Stroop test, middle- and old-aged fibromyalgia patients did not show prefrontal cortex activity similar to that of middle- and old-aged healthy subjects; furthermore they also exhibited reduced inhibitory function of the default mode network.
- 1 January 2023
- Published by Society of Physical Therapy Science in Rigakuryoho Kagaku
- Vol. 38 (5) , 338-344
Open AccessStroop test実施中の中高年線維筋痛症患者における前頭前野の活動について
[Purpose] We measured prefrontal cortex activity during the Stroop test in middle- and old-aged fibromyalgia patients and middle- and old-aged healthy subjects using functional near-infrared spectroscopy, and examined and compared the results. [Participants and Methods] The Stroop test was performed in two groups of 10 middle- and old-aged fibromyalgia patients (experimental group) and 29 middle- and old-aged healthy subjects (control group), and prefrontal cortex activity was measured by functional near-infrared spectroscopy. Oxy-Hb values and Δoxy-Hb values representing task-induced deactivation were compared in two groups and three prefrontal regions, i.e., the right and left dorsolateral prefrontal cortex and the frontal pole. [Results] During the Stroop test, oxy-Hb values in the right dorsolateral prefrontal cortex were significantly higher in the middle- and old-aged healthy subjects than in middle- and old-aged fibromyalgia patients. The Δoxy-Hb value in the frontal pole of the middle- and old-aged fibromyalgia patients tended to be higher than those in the left and right dorsolateral prefrontal cortex. [Conclusion] During the Stroop test, middle- and old-aged fibromyalgia patients did not show prefrontal cortex activity similar to that of middle- and old-aged healthy subjects; furthermore they also exhibited reduced inhibitory function of the default mode network.
- Open Access
- 26 May 2021
- Published by Frontiers Media SA in Frontiers in Pain Research
- Vol. 2, 644391
Impact of Non-steroidal Anti-inflammatory Drug Administration for 12 Months on Renal Function
Background: The use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with an increased risk of renal complications. Resolution of renal adverse effects after NSAID administration has been observed after short-term use. Thus, the present study aimed to investigate a series of patients with chronic musculoskeletal pain who underwent long-term NSAID administration followed by switching to tramadol hydrochloride/acetaminophen (TA) combination tablets to study the impact of NSAID-induced renal adverse effects.Methods: This was a longitudinal retrospective study of 99 patients with chronic musculoskeletal pain. The patients were administrated with NSAIDs daily during the first 12 months, followed by daily TA combination tablets for 12 months. Estimated glomerular filtration rate (eGFR) and serum levels of aspartate aminotransferase and alanine transaminase were measured at baseline, after NSAID administration and after TA administration.Results: eGFR was significantly reduced after 12-month NSAID administration (median, from 84.0 to 72.8 ml/min/1.73 m2), and the reduction was not shown after the subsequent 12-month TA administration (median, 71.5 ml/min/1.73 m2). Reduction in eGFR was less in patients who received celecoxib (median, −1.8 ml/min/1.73 m2) during the first 12 months. There was no significant difference in aspartate aminotransferase and alanine transaminase in each period.Conclusions: Thus, patients receiving NSAIDs for 12 months displayed both reversible and irreversible reduction of eGFR upon cessation of NSAIDs and switching to TA. Our data highlight the potential safety benefit of utilizing multimodal analgesic therapies to minimize the chronic administration of NSAIDs.
- 26 May 2021
- Published by Frontiers Media SA in Frontiers in Pain Research
- Vol. 2, 644391
Open AccessImpact of Non-steroidal Anti-inflammatory Drug Administration for 12 Months on Renal Function
Background: The use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with an increased risk of renal complications. Resolution of renal adverse effects after NSAID administration has been observed after short-term use. Thus, the present study aimed to investigate a series of patients with chronic musculoskeletal pain who underwent long-term NSAID administration followed by switching to tramadol hydrochloride/acetaminophen (TA) combination tablets to study the impact of NSAID-induced renal adverse effects.Methods: This was a longitudinal retrospective study of 99 patients with chronic musculoskeletal pain. The patients were administrated with NSAIDs daily during the first 12 months, followed by daily TA combination tablets for 12 months. Estimated glomerular filtration rate (eGFR) and serum levels of aspartate aminotransferase and alanine transaminase were measured at baseline, after NSAID administration and after TA administration.Results: eGFR was significantly reduced after 12-month NSAID administration (median, from 84.0 to 72.8 ml/min/1.73 m2), and the reduction was not shown after the subsequent 12-month TA administration (median, 71.5 ml/min/1.73 m2). Reduction in eGFR was less in patients who received celecoxib (median, −1.8 ml/min/1.73 m2) during the first 12 months. There was no significant difference in aspartate aminotransferase and alanine transaminase in each period.Conclusions: Thus, patients receiving NSAIDs for 12 months displayed both reversible and irreversible reduction of eGFR upon cessation of NSAIDs and switching to TA. Our data highlight the potential safety benefit of utilizing multimodal analgesic therapies to minimize the chronic administration of NSAIDs.
- Open Access
- 10 May 2021
- Published by Springer Nature in BMC Rheumatology
- Vol. 5 (1) , 1-6
Weather sensitivity associated with quality of life in patients with fibromyalgia
Background: Fibromyalgia is characterized by chronic widespread pain, and more than half of patients with fibromyalgia report that weather-related variables aggravate their symptoms. However, the differences in actual symptoms have not been measured between those with and without weather sensitivity. The present study aimed to investigate whether weather sensitivity associated with the minimal clinically important difference values of quality of life in patients with fibromyalgia, between those with and without weather sensitivity. Methods: Sixty-four consecutive outpatients with fibromyalgia on their first visit to our tertiary center were included. Weather sensitivity was measured using self-perceived symptoms. Pain intensity was measured using the 0–10 Numerical Rating Scale (NRS). Quality of life was measured using the Euro Quality of life-5 Dimensions-3 level (EQ-5D-3L) scale. The variables were subjected to univariable and multivariable analysis using the EQ-5D-3L scale. Results: The mean age of the patients was 50 years. Forty-eight patients (75%) were women. The mean EQ-5D-3L score was 0.55. Thirty-seven patients (58%) reported weather sensitivity. In univariable analysis, the welfare recipient, weather sensitivity, and NRS values were associated with EQ-5D-3L scale scores. In multivariable analysis, NRS value and weather sensitivity were independently associated with EQ-5D-3L scale scores. The NRS and EQ-5D-3L scale scores were significantly worse in those with weather sensitivity than those without weather sensitivity. The difference in NRS values was less than 1.5 points between groups. The differences in EQ-5D-3L scale scores were 0.16 points between groups. Conclusions: Weather sensitivity was significantly associated with quality of life in patients with fibromyalgia. There was an association with weather sensitivity and the minimal clinically important difference values of quality of life in patients with fibromyalgia. The presence of weather sensitivity could have a key role in the quality of life in patients with fibromyalgia.
- 10 May 2021
- Published by Springer Nature in BMC Rheumatology
- Vol. 5 (1) , 1-6
Open AccessWeather sensitivity associated with quality of life in patients with fibromyalgia
Background: Fibromyalgia is characterized by chronic widespread pain, and more than half of patients with fibromyalgia report that weather-related variables aggravate their symptoms. However, the differences in actual symptoms have not been measured between those with and without weather sensitivity. The present study aimed to investigate whether weather sensitivity associated with the minimal clinically important difference values of quality of life in patients with fibromyalgia, between those with and without weather sensitivity. Methods: Sixty-four consecutive outpatients with fibromyalgia on their first visit to our tertiary center were included. Weather sensitivity was measured using self-perceived symptoms. Pain intensity was measured using the 0–10 Numerical Rating Scale (NRS). Quality of life was measured using the Euro Quality of life-5 Dimensions-3 level (EQ-5D-3L) scale. The variables were subjected to univariable and multivariable analysis using the EQ-5D-3L scale. Results: The mean age of the patients was 50 years. Forty-eight patients (75%) were women. The mean EQ-5D-3L score was 0.55. Thirty-seven patients (58%) reported weather sensitivity. In univariable analysis, the welfare recipient, weather sensitivity, and NRS values were associated with EQ-5D-3L scale scores. In multivariable analysis, NRS value and weather sensitivity were independently associated with EQ-5D-3L scale scores. The NRS and EQ-5D-3L scale scores were significantly worse in those with weather sensitivity than those without weather sensitivity. The difference in NRS values was less than 1.5 points between groups. The differences in EQ-5D-3L scale scores were 0.16 points between groups. Conclusions: Weather sensitivity was significantly associated with quality of life in patients with fibromyalgia. There was an association with weather sensitivity and the minimal clinically important difference values of quality of life in patients with fibromyalgia. The presence of weather sensitivity could have a key role in the quality of life in patients with fibromyalgia.
- Open Access
- 3 November 2020
- Published by Springer Nature in Research Square
Impact of nonsteroidal anti-inflammatory drug administration for 12 months on renal function
Background: The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with an increased risk of renal complications. Resolution of renal side effects following NSAID administration has been observed following short-term use. Thus, the aim of the present study was to investigate a series of patients with chronic musculoskeletal pain who underwent long-term NSAIDs administration followed by switching to TA combination tablets to study the impact of NSAID-induced renal side effects.Methods: This was a longitudinal retrospective study of 99 patients with chronic musculoskeletal pain. The patients were administrated NSAIDs daily during the first 12 months followed by daily TA combination tablets for 12 months. Estimated glomerular filtration rate (eGFR) and serum levels of aspartate aminotransferase and alanine transaminase were measured at baseline, after NSAIDs administration, and after TA administration.Results: eGFR was significantly reduced following 12-month NSAIDs administration (median, from 84.0 mL/min/1.73 m2 to 72.8 mL/min/1.73 m2), and the reduction was not shown following the subsequent 12-month TA administration (median, 71.5 mL/min/1.73 m2). Reduction in eGFR was less in patients who received celecoxib (median, -1.8 mL/min/1.73 m2) during the first 12 months. There was no significant difference in aspartate aminotransferase and alanine transaminase in each period.Conclusions: Thus, patients receiving NSAIDs for 12 months displayed both reversible and irreversible reduction of eGFR upon cessation of NSAIDs and switching to TA. Our data highlights the potential safety benefit of utilizing multimodal analgesic therapies to minimize the chronic administration of NSAIDs.
- 3 November 2020
- Published by Springer Nature in Research Square
Open AccessImpact of nonsteroidal anti-inflammatory drug administration for 12 months on renal function
Background: The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with an increased risk of renal complications. Resolution of renal side effects following NSAID administration has been observed following short-term use. Thus, the aim of the present study was to investigate a series of patients with chronic musculoskeletal pain who underwent long-term NSAIDs administration followed by switching to TA combination tablets to study the impact of NSAID-induced renal side effects.Methods: This was a longitudinal retrospective study of 99 patients with chronic musculoskeletal pain. The patients were administrated NSAIDs daily during the first 12 months followed by daily TA combination tablets for 12 months. Estimated glomerular filtration rate (eGFR) and serum levels of aspartate aminotransferase and alanine transaminase were measured at baseline, after NSAIDs administration, and after TA administration.Results: eGFR was significantly reduced following 12-month NSAIDs administration (median, from 84.0 mL/min/1.73 m2 to 72.8 mL/min/1.73 m2), and the reduction was not shown following the subsequent 12-month TA administration (median, 71.5 mL/min/1.73 m2). Reduction in eGFR was less in patients who received celecoxib (median, -1.8 mL/min/1.73 m2) during the first 12 months. There was no significant difference in aspartate aminotransferase and alanine transaminase in each period.Conclusions: Thus, patients receiving NSAIDs for 12 months displayed both reversible and irreversible reduction of eGFR upon cessation of NSAIDs and switching to TA. Our data highlights the potential safety benefit of utilizing multimodal analgesic therapies to minimize the chronic administration of NSAIDs.